Importantly, a trend for increased mRNA expression of CX3CL1 and CXCL10 in tumor cells was also observed upon dabrafenib treatment in vivo (Fig. 5e-h), suggesting that such a recruitment could take place in vivo. The gene discussed is CXCL10; the disease is neoplasm.